Becton, Dickinson and Company BDX Property, plant, and equipment additions

Property, plant, and equipment additions at other companies

Thermo Fisher ScientificTMO

——

West Pharmaceutical ServicesWST

——

Medical$469M+7.1%

Revenue$4.7B+5.2%

Gross profit$2.2B+15.7%

Operating income$93.0M-75.7%

Net income-$311.0M-201%

EPS (diluted)-$1.11-204%

Cash & equivalents$1.0B+49.0%

Total debt$14.7B-16.8%

Total equity$24.1B-4.4%

Total assets$50.8B-6.7%

Operating cash flow$671.0M—

CapEx$125.0M+9.6%

Free cash flow$546.0M—

Market cap$42.96B-12.6%

Enterprise value$56.65B-14.0%

P/E37.8×+6.7×

P/S2×-0.4×

Gross margin46.8%+2.5pp

Operating margin10.4%+0.1pp

Net margin5.3%-2.1pp

FCF margin16.4%—

Return on equity4.6%-1.3pp

Debt / equity0.6×-0.1×

Current ratio0.9×-0.2×